NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 11661.05 72.70 0.63%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Teva Pharmaceutical Industries Limited (NYSE: TEVA)

 
TEVA Technical Analysis
5
As on 31st Oct 2017 TEVA Share Price closed @ 13.80 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 28.57 & Strong Sell for SHORT-TERM with Stoploss of 16.23 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

TEVA Share Price

Open 13.85 Change Price %
High 14.12 1 Day 0.25 1.85
Low 13.37 1 Week 0.00 0.00
Close 13.80 1 Month -1.18 -7.88
Volume 32362947 1 Year -26.85 -66.05
52 Week High 41.19 | 52 Week Low 13.26
 
NYSE USA Most Active Stocks
RAI 65.40 -2.23%
EMC 29.05 0.97%
GE 20.16 -1.22%
AKS 4.59 -21.54%
PCS 11.84 -0.92%
AMD 10.98 0.83%
WSH 47.18 -2.86%
JNS 14.17 -0.56%
XLS 24.66 -0.64%
SWY 35.10 -0.11%
 
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
GLF 0.34 25.93%
GLF 0.34 25.93%
TREX 109.45 25.65%
HZO 18.55 22.04%
SSD 55.74 14.62%
TBI 27.10 14.11%
SSTK 38.99 13.84%
KAI 113.60 13.09%
 
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
 
 
TEVA
Daily Charts
TEVA
Intraday Charts
Whats New @
Bazaartrend
TEVA
Free Analysis
 
TEVA Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE14.50
RESISTANCE14.21
SUPPORT13.39
SUPPORT13.10
SUPPORT0.00
SUPPORT0.00
 
TEVA Target for Month July
4th UP TARGET25.17
3rd UP TARGET21.52
2nd UP TARGET19.27
1st UP TARGET17.02
1st DOWN TARGET10.58
2nd DOWN TARGET8.33
3rd DOWN TARGET6.08
4th DOWN TARGET2.43
 
TEVA Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
TEVA Target for Year 2019
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
TEVA Other Details
Segment EQ
Market Capital 35553280000.00
Sector Healthcare
Industry Drug Manufacturers - Other
Offical website http://www.tevapharm.com
 
TEVA Address
TEVA
5 Basel Street
Petach Tikva, 49131
Israel
Phone: 972 3 926 7267
Fax: 972 3 923 4050
 
TEVA Latest News
 
Your Comments and Response on Teva Pharmaceutical Industries Limited
 
TEVA Business Profile
Teva Pharmaceutical Industries Limited, together with its subsidiaries, develops, manufactures, sells, and distributes pharmaceutical products worldwide. The company offers generic pharmaceutical products; and basic chemicals, as well as specialized product families. Its products include Copaxone for multiple sclerosis; Azilect for the treatment of Parkinson’s disease; Provigil and Nuvigil to treat excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorders; Fentora and Actiq to treat pain in opioid-tolerant adult patients with cancer; and Amrix for muscle spasm in acute, painful, and musculoskeletal conditions. The company also offers Treanda to treat chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma; Tevagrastim that stimulate the production of white blood cells; Lonquex, which reduces the duration of neutropenia and incidence of febrile neutropenia in adult patients; Eporatio that stimulates the production of red blood cells; and Synribo for chronic myeloid leukemia. In addition, it provides ProAir for the treatment of bronchospasm; QVAR for the treatment of asthma; Qnasl Nasal Aerosol for nasal allergy symptoms in adults; Plan B One-Step and Quartette, which prevents pregnancy; Seasonique and LoSeasonique that are extended-cycle oral contraceptives; Zoely, a regimen combination contraceptive oral pill; and ParaGard, a non-hormonal intrauterine contraceptive. Further, the company offers Enjuvia for vasomotor symptoms associated with menopause; hormone therapy treatments for menopause/perimenopause; therapies for infertility and urinary incontinence; and manufactures active pharmaceutical ingredients. It also distributes third party products. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
 
2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service